DeepMed Research

HADASSAH MEDICAL ORGANIZATION (CC)

🇮🇱Israel

Country: 🇮🇱Israel

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia

Conditions: Hyponatremia
SIADH

First Posted Date: 2012-01-12

Last Posted Date: 2012-01-12

Lead Sponsor: Hadassah Medical Organization

Target Recruit Count: 500

Registration Number: NCT01509170

Locations: 🇮🇱
Hadassah- Hebrew-University Medical Center, Jerusalem, Israel
🇮🇱
Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Comparison of Soft and Hard Tissue Thickness in the Anterior Regions of the Upper and Lower Jaws Taken From CBCT Versus Clinical Measurements

Conditions: Soft and Hard Tissue Biotype

First Posted Date: 2012-01-11

Last Posted Date: 2012-01-11

Lead Sponsor: Hadassah Medical Organization

Target Recruit Count: 100

Registration Number: NCT01507961

Comparing the Expected Benefit of Extra-corporeal-shockwave Therapy (ESWT) Treatment to Standard Care in Treating Diabetic Foot Ulcers

Not Applicable

Conditions: Diabetic Foot

Interventions: Device: shock wave therapy
Procedure: standard of care
Device: dermagold shockwave

First Posted Date: 2011-12-26

Last Posted Date: 2011-12-26

Lead Sponsor: Hadassah Medical Organization

Target Recruit Count: 300

Registration Number: NCT01499472

Study Assessing Safety and Efficacy of B-cure Laser Treating Diabetic Chronic Wounds

Phase 1

Conditions: Diabetic Foot Ulcer

Interventions: Device: standard hoem treatment
Device: LLLT-808 B-cure laser machine

First Posted Date: 2011-12-16

Last Posted Date: 2013-03-22

Lead Sponsor: Hadassah Medical Organization

Registration Number: NCT01493895

Locations: 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel

The Effect of Marketing Variable on Effect of Active Drugs

Not Applicable

Conditions: Pain

Interventions: Drug: Free of charge
Drug: High price
Drug: Low price
Drug: Low price participants aware paying part
Drug: No price

First Posted Date: 2011-12-16

Last Posted Date: 2011-12-16

Lead Sponsor: Hadassah Medical Organization

Target Recruit Count: 220

Registration Number: NCT01493908

Locations: 🇮🇱
Department of Family Medicine, Hebrew University, JerusaelmIsrael, Jerusalem, Israel

Acidity Level of Blood From Primary Molar's Pulp While Undergoing Pulpotomy or Pulpectomy Procedure

Completed

Conditions: Healthy

First Posted Date: 2011-12-06

Last Posted Date: 2022-03-16

Lead Sponsor: Hadassah Medical Organization

Target Recruit Count: 87

Registration Number: NCT01486537

Locations: 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel, Jerusalem, Israel

EEG Objectification in Neuropsychiatry

Not Applicable

Conditions: Personality Disorder
Depression
Neurodegeneration
Alzheimer's Disease
Epilepsy

Interventions: Device: EEG recording

First Posted Date: 2011-11-22

Last Posted Date: 2011-11-22

Lead Sponsor: Hadassah Medical Organization

Target Recruit Count: 100

Registration Number: NCT01476228

Locations: 🇮🇱
HMO, Jerusalem, Israel

Does Discontinuation of Aspirin Treatment Following Head Trauma Decrease the Incidence of Chronic Subdural Hematoma?

Phase 4

Conditions: Head Trauma
Traumatic Brain Injury
Chronic Subdural Hematoma

Interventions: Drug: discontinuation of aspirin therapy
Drug: continuation of aspirin therapy

First Posted Date: 2011-11-11

Last Posted Date: 2012-01-18

Lead Sponsor: Hadassah Medical Organization

Target Recruit Count: 100

Registration Number: NCT01470040

Locations: 🇮🇱
Hadassah Medical Center, Jerusalem, Israel

Perception and Multisensory Integration in Neurological Patients Using fMRI

Not Applicable

Conditions: Acute Inflammatory Demyelinating Polyradiculoneuropathy
Myasthenia Gravis
Stroke
Anosognosia
Asomatognosia

Interventions: Device: Siemens magnetom avanto1.5 Tesla, Siemens magnetom trio A Tim system 3 Tesla

First Posted Date: 2011-11-10

Last Posted Date: 2011-11-10

Lead Sponsor: Hadassah Medical Organization

Target Recruit Count: 30

Registration Number: NCT01469858

Locations: 🇮🇱
Hadassah Medical Organization, Jerusalem, Israel

Safety Study of Use of Hyaluronic Acid Gel To Prevent Intrauterine Adhesions In Hysteroscopic Surgery

Early Phase 1

Conditions: Tissue Adhesions

Interventions: Drug: Hyaluronan

First Posted Date: 2011-11-03

Last Posted Date: 2011-11-03

Lead Sponsor: Hadassah Medical Organization

Target Recruit Count: 10

Registration Number: NCT01464528

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy